Institute Of Medical Biology, Chinese Academy Of Medical Sciences
Clinical trials sponsored by Institute Of Medical Biology, Chinese Academy Of Medical Sciences, explained in plain language.
-
First human trial launches for Dual-Virus HFMD vaccine
⭐️ VACCINE ⭐️ Not yet recruitingThis is an early-stage study to test the safety and initial immune response of a new vaccine designed to prevent Hand, Foot and Mouth Disease (HFMD). The vaccine targets two common viruses that cause HFMD. The trial will enroll 144 healthy participants, from infants as young as 6…
Phase: PHASE1 • Sponsor: Institute of Medical Biology, Chinese Academy of Medical Sciences • Aim: ⭐️ VACCINE ⭐️
Last updated Apr 03, 2026 14:41 UTC
-
New booster shot trial aims to protect against three dangerous diseases
⭐️ VACCINE ⭐️ Not yet recruitingThis study is testing a new version of the Tdap vaccine, which protects against tetanus, diphtheria, and whooping cough (pertussis). Researchers want to see if this vaccine, which contains fewer antigens, is safe and triggers a good immune response in people aged 6 years and olde…
Phase: PHASE1, PHASE2 • Sponsor: Institute of Medical Biology, Chinese Academy of Medical Sciences • Aim: ⭐️ VACCINE ⭐️
Last updated Apr 01, 2026 14:43 UTC